Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2005-2023
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2005
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2005
Parameters | Defects | Activity | Time to normalization |
Procoagulant factors | |||
Factors II, VII, IX, X (vitamin K-dependent) | ↓ quantity | ↓ | 6 mo |
Fibrinogen | Dysfunctional | ↓ | 1 yr |
Platelet | Hyporesponsiveness | ↓ | 2-4 wk |
vWF | ↑ quantity/Hyperfunction | ↑ | / |
Factor VIII | ↑ quantity | ↑ | / |
Anticoagulant factors | |||
AT-III | ↓ quantity/dysfunctional | ↓ | 6 mo |
Heparin Cofactor II | ↓ quantity | ↓ | 6 mo |
TFPI | ↓ quantity | ↓ | 6 mo |
α2-antiplasmin | ↓ quantity | ↓ | 6 mo |
α1-antitrypsin | ↓ quantity | ↓ | 6 mo |
C 1 esterase inhibitor | ↓ quantity | ↓ | 6 mo |
Protein C | ↓ quantity | ↓ | 6 mo |
Protein S | ↓ quantity | ↓ | 6 mo |
α2-macroglobulin | ↑ quantity | ↑ | 6 mo |
- Citation: Nacoti M, Corbella D, Fazzi F, Rapido F, Bonanomi E. Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol 2016; 22(6): 2005-2023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2005.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2005